Anthony Bourne - Bioquell plc Insider

BIQLF -- USA Stock  

USD 7.18  0.00  0.00%

  Director
Mr. Tony R. Bourne is an Independent NonExecutive Director of Bioquell PLC. since March 2009. He Joined the Board in March 2009. He is currently a nonexecutive director at various companies including Barchester one of the UKs largest residential care home businesses Spire Healthcare the leading UK listed private hospital and healthcare provider and Chelsea and Westminster Health Charity one of the largest NHS charities. For nearly nine years up to late 2013 he was Chief Executive of the British Medical Association. Prior to joining the BMA as Chief Executive Tony was in investment banking for over 25 years.
Age: 61  Director Since 2009      
44 1264 835 835  http://www.bioquellplc.com

Management Efficiency

The company has return on total asset (ROA) of 6.36 % which means that it generated profit of $6.36 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 12.0 % meaning that it generated $12.0 on every $100 dollars invested by stockholders.

Similar Executives

Showing few of many executives

DIRECTOR Since

Angie RisleySmith Nephew plc
2017
Julie BrownSmith Nephew plc
2013
Ronda StrykerStryker Corporation
1984
Graham BakerSmith Nephew plc
2017
Brian LarcombeSmith Nephew plc
2014
Robin FreestoneSmith Nephew plc
2015
Edward LiddyAbbott Laboratories
2010
Allan GolstonStryker Corporation
2011
William LinkEdwards Lifesciences Corporatio
Richard AndersonMedtronic plc
2015
Kendall PowellMedtronic plc
2015
Gregory SantoraAlign Technology
2003
Edward LudwigBoston Scientific Corporation
2016
Martin SutterABIOMED
2008
Christopher BegleyZimmer Biomet Holdings
2012
Srikant DatarStryker Corporation
2009
Glenn TiltonAbbott Laboratories
2007
Kieran GallahueEdwards Lifesciences Corporatio
2015
Benjamin AndersonRayInogen
2013
Paul BisaroZimmer Biomet Holdings
2013
Howard CoxStryker Corporation
1974

Entity Summary

Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and traded on OTC Market. It employs 220 people.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 220 people.

Bioquell plc Leadership Team

Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Stock Performance Indicators

Did you try this?

Run Fundamentals Matrix Now

   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Fundamentals Matrix

Bioquell plc Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bioquell plc and Medtronic plc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com